0
Upcoming Allied Market Research
2023
Atherectomy Device Market

Atherectomy Device Market

by Product (Directional Atherectomy Systems, Photo-Ablative (Laser) Atherectomy Systems, Rotational Atherectomy Systems, Orbital Atherectomy Systems), by Applicatio (Peripheral Vascular Applications, Cardiovascular Applications, Neurovascular Applications) and by End User (Hospitals Surgical Centers, Ambulatory Care Centers, Research Laboratories Academic Institutes, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Report Code: A06259
Nov 2023 | Pages: NA
Tables: NA
Charts: NA
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Atherectomy Device Market

Request Now !

Atherectomy is a minimally invasive endovascular surgery for removal of atherosclerotic plaque from affected arteries. Atherectomy devices help and assist the atherectomyprocedure for cleaning the clogged arteries majorly calcium deposits. These devices are of four types namely; rotational, orbital, directional, and laser. Atherectomy involves using a catheterwith a sharp blade for cutting, sanding, shaving, or vaporizing atherosclerotic plaque from the arteries. This procedure is mainly used in treating peripheral and coronaryarterial disease as an alternative to angioplasty. This procedure has advantages over conventional procedures as it treats complex lesions, less dissection,and acute occlusion and reduces restenosis rate in humans. 

As per the data published by CDC, in 2016, the population suffering from peripheral artery disease (PAD) alone is approximately 8.5 million,including 12-20% of individuals older than age 60 in the U.S. alone. Moreover, in 2017, CDC published coronary heart disease (CHD) is the most common heart diseasekilling approximately 370,000 people in the U.S.every year.  Thus, this is expected to provide lucrative opportunities for the growth of theatherectomy device market. 

The factors such as rise inpreference for minimally invasive surgeries and increase inprevalence of peripheral & coronary heart diseases are expectedto boost the growth of the atherectomy device market in thecoming years. Furthermore, favorable medical reimbursement scenario from the government is anticipated to propel theatherectomy devicemarket growth. However, lack of skilled professionals and stringent regulatory scenario is expected to restrain the market growth.

The atherectomy device market is segmented on the basis ofproduct, application, end user, and region. Based on product, the market is categorized into directional atherectomy systems, orbital atherectomy systems, photo-ablative atherectomy systems, and rotational atherectomy systems. By application, itis classified into peripheral vascular applications, cardiovascular applications, and neurovascular applications. Based on end user, the market is divided into hospitals & surgical centers, ambulatory care centers, research laboratories & academic institutes, and others. Based on region, it is analyzed across North America, Asia-Pacific, Europe, and LAMEA. 

Major players operating in the atherectomy device market include Boston Scientific Corporation, Cardiovascular Systems, Inc., Avinger, Inc., Spectranetics Corporation (Philips Holding USA Inc.), Medtronic plc, St. Jude Medical, Inc. (Abbott Laboratories), Straub Medical AG, Bard Peripheral Vascular, Inc., Volcano Corporation, and Terumo Corporation. Some of the other players operating in the market are Cardinal Health (Cordis) and Biomerics, LLC.The prominent players in the market have adopted various strategies for increasing their atherectomy device market share. For instance, recently, in 2019, Rex Medical received FDA clearance for its revolution peripheral atherectomy system. In addition, Cardiovascular Systems, Inc. received FDA approval of the Coronary ViperWire Advance with Flex Tip. It is the latest advancement for CSI’s coronary Diamondback 360 that is used to treat calcific coronary artery disease. 

Key Benefits For Stakeholders

  • This report provides a detailed quantitative analysis of the current atherectomy device market trends and forecast estimations which assists to identify the prevailing market opportunities. 

  • An in-depth atherectomy device market analysis includes analysis of various regions and is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.

  • A comprehensive analysis of the factors that drive and restrain the growth of the global atherectomy device market is provided.

  • Region-wise and country-wise atherectomy device Market conditions are comprehensively analyzed in this report.

  • The projections in this report are made by analyzing the current atherectomy device market trends and fu-ture market potential in terms of value.

  • An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.

  • The key players within the market are profiled in this report and their strategies are analyzed thoroughly, which helps in understanding competitive outlook of the global market.  

Atherectomy Device Market Report Highlights

Aspects Details
By Product
  • Directional Atherectomy Systems
  • Photo-Ablative (Laser) Atherectomy Systems
  • Rotational Atherectomy Systems
  • Orbital Atherectomy Systems
By Applicatio
  • Peripheral Vascular Applications
  • Cardiovascular Applications
  • Neurovascular Applications
By End User
  • Hospitals & Surgical Centers
  • Ambulatory Care Centers
  • Research Laboratories & Academic Institutes
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Volcano Corporation, Boston Scientific Corporation, Medtronic plc, Cardiovascular Systems Inc., Bard Peripheral Vascular Inc., Cardinal Health (Cordis), Avinger Inc., Spectranetics Corporation (Philips Holding USA Inc.), Straub Medical AG, Terumo Corporation, St. Jude Medical Inc. (Abbott Laboratories)
 
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: ATHERECTOMY DEVICE MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. Directional Atherectomy Systems

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Photo-Ablative (Laser) Atherectomy Systems

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Rotational Atherectomy Systems

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Orbital Atherectomy Systems

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

  • CHAPTER 5: ATHERECTOMY DEVICE MARKET, BY APPLICATIO

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Applicatio

    • 5.2. Peripheral Vascular Applications

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Cardiovascular Applications

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Neurovascular Applications

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

  • CHAPTER 6: ATHERECTOMY DEVICE MARKET, BY END USER

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By End User

    • 6.2. Hospitals Surgical Centers

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Ambulatory Care Centers

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Research Laboratories Academic Institutes

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

    • 6.5. Others

      • 6.5.1. Key Market Trends, Growth Factors and Opportunities

      • 6.5.2. Market Size and Forecast, By Region

      • 6.5.3. Market Share Analysis, By Country

  • CHAPTER 7: ATHERECTOMY DEVICE MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Product

      • 7.2.3. Market Size and Forecast, By Applicatio

      • 7.2.4. Market Size and Forecast, By End User

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Atherectomy Device Market

        • 7.2.6.1. Market Size and Forecast, By Product
        • 7.2.6.2. Market Size and Forecast, By Applicatio
        • 7.2.6.3. Market Size and Forecast, By End User
      • 7.2.7. Canada Atherectomy Device Market

        • 7.2.7.1. Market Size and Forecast, By Product
        • 7.2.7.2. Market Size and Forecast, By Applicatio
        • 7.2.7.3. Market Size and Forecast, By End User
      • 7.2.8. Mexico Atherectomy Device Market

        • 7.2.8.1. Market Size and Forecast, By Product
        • 7.2.8.2. Market Size and Forecast, By Applicatio
        • 7.2.8.3. Market Size and Forecast, By End User
    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Product

      • 7.3.3. Market Size and Forecast, By Applicatio

      • 7.3.4. Market Size and Forecast, By End User

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Atherectomy Device Market

        • 7.3.6.1. Market Size and Forecast, By Product
        • 7.3.6.2. Market Size and Forecast, By Applicatio
        • 7.3.6.3. Market Size and Forecast, By End User
      • 7.3.7. Germany Atherectomy Device Market

        • 7.3.7.1. Market Size and Forecast, By Product
        • 7.3.7.2. Market Size and Forecast, By Applicatio
        • 7.3.7.3. Market Size and Forecast, By End User
      • 7.3.8. Italy Atherectomy Device Market

        • 7.3.8.1. Market Size and Forecast, By Product
        • 7.3.8.2. Market Size and Forecast, By Applicatio
        • 7.3.8.3. Market Size and Forecast, By End User
      • 7.3.9. Spain Atherectomy Device Market

        • 7.3.9.1. Market Size and Forecast, By Product
        • 7.3.9.2. Market Size and Forecast, By Applicatio
        • 7.3.9.3. Market Size and Forecast, By End User
      • 7.3.10. UK Atherectomy Device Market

        • 7.3.10.1. Market Size and Forecast, By Product
        • 7.3.10.2. Market Size and Forecast, By Applicatio
        • 7.3.10.3. Market Size and Forecast, By End User
      • 7.3.11. Russia Atherectomy Device Market

        • 7.3.11.1. Market Size and Forecast, By Product
        • 7.3.11.2. Market Size and Forecast, By Applicatio
        • 7.3.11.3. Market Size and Forecast, By End User
      • 7.3.12. Rest Of Europe Atherectomy Device Market

        • 7.3.12.1. Market Size and Forecast, By Product
        • 7.3.12.2. Market Size and Forecast, By Applicatio
        • 7.3.12.3. Market Size and Forecast, By End User
    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Product

      • 7.4.3. Market Size and Forecast, By Applicatio

      • 7.4.4. Market Size and Forecast, By End User

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Atherectomy Device Market

        • 7.4.6.1. Market Size and Forecast, By Product
        • 7.4.6.2. Market Size and Forecast, By Applicatio
        • 7.4.6.3. Market Size and Forecast, By End User
      • 7.4.7. Japan Atherectomy Device Market

        • 7.4.7.1. Market Size and Forecast, By Product
        • 7.4.7.2. Market Size and Forecast, By Applicatio
        • 7.4.7.3. Market Size and Forecast, By End User
      • 7.4.8. India Atherectomy Device Market

        • 7.4.8.1. Market Size and Forecast, By Product
        • 7.4.8.2. Market Size and Forecast, By Applicatio
        • 7.4.8.3. Market Size and Forecast, By End User
      • 7.4.9. South Korea Atherectomy Device Market

        • 7.4.9.1. Market Size and Forecast, By Product
        • 7.4.9.2. Market Size and Forecast, By Applicatio
        • 7.4.9.3. Market Size and Forecast, By End User
      • 7.4.10. Australia Atherectomy Device Market

        • 7.4.10.1. Market Size and Forecast, By Product
        • 7.4.10.2. Market Size and Forecast, By Applicatio
        • 7.4.10.3. Market Size and Forecast, By End User
      • 7.4.11. Thailand Atherectomy Device Market

        • 7.4.11.1. Market Size and Forecast, By Product
        • 7.4.11.2. Market Size and Forecast, By Applicatio
        • 7.4.11.3. Market Size and Forecast, By End User
      • 7.4.12. Malaysia Atherectomy Device Market

        • 7.4.12.1. Market Size and Forecast, By Product
        • 7.4.12.2. Market Size and Forecast, By Applicatio
        • 7.4.12.3. Market Size and Forecast, By End User
      • 7.4.13. Indonesia Atherectomy Device Market

        • 7.4.13.1. Market Size and Forecast, By Product
        • 7.4.13.2. Market Size and Forecast, By Applicatio
        • 7.4.13.3. Market Size and Forecast, By End User
      • 7.4.14. Rest of Asia Pacific Atherectomy Device Market

        • 7.4.14.1. Market Size and Forecast, By Product
        • 7.4.14.2. Market Size and Forecast, By Applicatio
        • 7.4.14.3. Market Size and Forecast, By End User
    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Product

      • 7.5.3. Market Size and Forecast, By Applicatio

      • 7.5.4. Market Size and Forecast, By End User

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Atherectomy Device Market

        • 7.5.6.1. Market Size and Forecast, By Product
        • 7.5.6.2. Market Size and Forecast, By Applicatio
        • 7.5.6.3. Market Size and Forecast, By End User
      • 7.5.7. South Africa Atherectomy Device Market

        • 7.5.7.1. Market Size and Forecast, By Product
        • 7.5.7.2. Market Size and Forecast, By Applicatio
        • 7.5.7.3. Market Size and Forecast, By End User
      • 7.5.8. Saudi Arabia Atherectomy Device Market

        • 7.5.8.1. Market Size and Forecast, By Product
        • 7.5.8.2. Market Size and Forecast, By Applicatio
        • 7.5.8.3. Market Size and Forecast, By End User
      • 7.5.9. UAE Atherectomy Device Market

        • 7.5.9.1. Market Size and Forecast, By Product
        • 7.5.9.2. Market Size and Forecast, By Applicatio
        • 7.5.9.3. Market Size and Forecast, By End User
      • 7.5.10. Argentina Atherectomy Device Market

        • 7.5.10.1. Market Size and Forecast, By Product
        • 7.5.10.2. Market Size and Forecast, By Applicatio
        • 7.5.10.3. Market Size and Forecast, By End User
      • 7.5.11. Rest of LAMEA Atherectomy Device Market

        • 7.5.11.1. Market Size and Forecast, By Product
        • 7.5.11.2. Market Size and Forecast, By Applicatio
        • 7.5.11.3. Market Size and Forecast, By End User
  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning,2022

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Boston Scientific Corporation

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Cardiovascular Systems Inc.

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Avinger Inc.

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. Spectranetics Corporation (Philips Holding USA Inc.)

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. Medtronic Plc

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. St. Jude Medical Inc. (Abbott Laboratories)

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Straub Medical AG

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. Bard Peripheral Vascular Inc.

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. Volcano Corporation

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. Terumo Corporation

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

    • 9.11. Cardinal Health (Cordis)

      • 9.11.1. Company Overview

      • 9.11.2. Key Executives

      • 9.11.3. Company Snapshot

      • 9.11.4. Operating Business Segments

      • 9.11.5. Product Portfolio

      • 9.11.6. Business Performance

      • 9.11.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL ATHERECTOMY DEVICE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL ATHERECTOMY DEVICE MARKET FOR DIRECTIONAL ATHERECTOMY SYSTEMS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL ATHERECTOMY DEVICE MARKET FOR PHOTO-ABLATIVE (LASER) ATHERECTOMY SYSTEMS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL ATHERECTOMY DEVICE MARKET FOR ROTATIONAL ATHERECTOMY SYSTEMS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL ATHERECTOMY DEVICE MARKET FOR ORBITAL ATHERECTOMY SYSTEMS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL ATHERECTOMY DEVICE MARKET, BY APPLICATIO, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL ATHERECTOMY DEVICE MARKET FOR PERIPHERAL VASCULAR APPLICATIONS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL ATHERECTOMY DEVICE MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL ATHERECTOMY DEVICE MARKET FOR NEUROVASCULAR APPLICATIONS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL ATHERECTOMY DEVICE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL ATHERECTOMY DEVICE MARKET FOR HOSPITALS SURGICAL CENTERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL ATHERECTOMY DEVICE MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL ATHERECTOMY DEVICE MARKET FOR RESEARCH LABORATORIES ACADEMIC INSTITUTES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. GLOBAL ATHERECTOMY DEVICE MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. GLOBAL ATHERECTOMY DEVICE MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. NORTH AMERICA ATHERECTOMY DEVICE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. NORTH AMERICA ATHERECTOMY DEVICE, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 18. NORTH AMERICA ATHERECTOMY DEVICE, BY APPLICATIO, 2022-2032 ($MILLION)
  • TABLE 19. NORTH AMERICA ATHERECTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 20. U.S. ATHERECTOMY DEVICE, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 21. U.S. ATHERECTOMY DEVICE, BY APPLICATIO, 2022-2032 ($MILLION)
  • TABLE 22. U.S. ATHERECTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 23. CANADA ATHERECTOMY DEVICE, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 24. CANADA ATHERECTOMY DEVICE, BY APPLICATIO, 2022-2032 ($MILLION)
  • TABLE 25. CANADA ATHERECTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 26. MEXICO ATHERECTOMY DEVICE, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 27. MEXICO ATHERECTOMY DEVICE, BY APPLICATIO, 2022-2032 ($MILLION)
  • TABLE 28. MEXICO ATHERECTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 29. EUROPE ATHERECTOMY DEVICE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 30. EUROPE ATHERECTOMY DEVICE, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 31. EUROPE ATHERECTOMY DEVICE, BY APPLICATIO, 2022-2032 ($MILLION)
  • TABLE 32. EUROPE ATHERECTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 33. FRANCE ATHERECTOMY DEVICE, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 34. FRANCE ATHERECTOMY DEVICE, BY APPLICATIO, 2022-2032 ($MILLION)
  • TABLE 35. FRANCE ATHERECTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 36. GERMANY ATHERECTOMY DEVICE, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 37. GERMANY ATHERECTOMY DEVICE, BY APPLICATIO, 2022-2032 ($MILLION)
  • TABLE 38. GERMANY ATHERECTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 39. ITALY ATHERECTOMY DEVICE, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 40. ITALY ATHERECTOMY DEVICE, BY APPLICATIO, 2022-2032 ($MILLION)
  • TABLE 41. ITALY ATHERECTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 42. SPAIN ATHERECTOMY DEVICE, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 43. SPAIN ATHERECTOMY DEVICE, BY APPLICATIO, 2022-2032 ($MILLION)
  • TABLE 44. SPAIN ATHERECTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 45. UK ATHERECTOMY DEVICE, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 46. UK ATHERECTOMY DEVICE, BY APPLICATIO, 2022-2032 ($MILLION)
  • TABLE 47. UK ATHERECTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 48. RUSSIA ATHERECTOMY DEVICE, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 49. RUSSIA ATHERECTOMY DEVICE, BY APPLICATIO, 2022-2032 ($MILLION)
  • TABLE 50. RUSSIA ATHERECTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 51. REST OF EUROPE ATHERECTOMY DEVICE, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 52. REST OF EUROPE ATHERECTOMY DEVICE, BY APPLICATIO, 2022-2032 ($MILLION)
  • TABLE 53. REST OF EUROPE ATHERECTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 54. ASIA-PACIFIC ATHERECTOMY DEVICE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 55. ASIA-PACIFIC ATHERECTOMY DEVICE, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 56. ASIA-PACIFIC ATHERECTOMY DEVICE, BY APPLICATIO, 2022-2032 ($MILLION)
  • TABLE 57. ASIA-PACIFIC ATHERECTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 58. CHINA ATHERECTOMY DEVICE, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 59. CHINA ATHERECTOMY DEVICE, BY APPLICATIO, 2022-2032 ($MILLION)
  • TABLE 60. CHINA ATHERECTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 61. JAPAN ATHERECTOMY DEVICE, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 62. JAPAN ATHERECTOMY DEVICE, BY APPLICATIO, 2022-2032 ($MILLION)
  • TABLE 63. JAPAN ATHERECTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 64. INDIA ATHERECTOMY DEVICE, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 65. INDIA ATHERECTOMY DEVICE, BY APPLICATIO, 2022-2032 ($MILLION)
  • TABLE 66. INDIA ATHERECTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 67. SOUTH KOREA ATHERECTOMY DEVICE, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 68. SOUTH KOREA ATHERECTOMY DEVICE, BY APPLICATIO, 2022-2032 ($MILLION)
  • TABLE 69. SOUTH KOREA ATHERECTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 70. AUSTRALIA ATHERECTOMY DEVICE, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 71. AUSTRALIA ATHERECTOMY DEVICE, BY APPLICATIO, 2022-2032 ($MILLION)
  • TABLE 72. AUSTRALIA ATHERECTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 73. THAILAND ATHERECTOMY DEVICE, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 74. THAILAND ATHERECTOMY DEVICE, BY APPLICATIO, 2022-2032 ($MILLION)
  • TABLE 75. THAILAND ATHERECTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 76. MALAYSIA ATHERECTOMY DEVICE, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 77. MALAYSIA ATHERECTOMY DEVICE, BY APPLICATIO, 2022-2032 ($MILLION)
  • TABLE 78. MALAYSIA ATHERECTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 79. INDONESIA ATHERECTOMY DEVICE, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 80. INDONESIA ATHERECTOMY DEVICE, BY APPLICATIO, 2022-2032 ($MILLION)
  • TABLE 81. INDONESIA ATHERECTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 82. REST OF ASIA PACIFIC ATHERECTOMY DEVICE, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 83. REST OF ASIA PACIFIC ATHERECTOMY DEVICE, BY APPLICATIO, 2022-2032 ($MILLION)
  • TABLE 84. REST OF ASIA PACIFIC ATHERECTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 85. LAMEA ATHERECTOMY DEVICE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 86. LAMEA ATHERECTOMY DEVICE, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 87. LAMEA ATHERECTOMY DEVICE, BY APPLICATIO, 2022-2032 ($MILLION)
  • TABLE 88. LAMEA ATHERECTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 89. BRAZIL ATHERECTOMY DEVICE, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 90. BRAZIL ATHERECTOMY DEVICE, BY APPLICATIO, 2022-2032 ($MILLION)
  • TABLE 91. BRAZIL ATHERECTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 92. SOUTH AFRICA ATHERECTOMY DEVICE, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 93. SOUTH AFRICA ATHERECTOMY DEVICE, BY APPLICATIO, 2022-2032 ($MILLION)
  • TABLE 94. SOUTH AFRICA ATHERECTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 95. SAUDI ARABIA ATHERECTOMY DEVICE, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 96. SAUDI ARABIA ATHERECTOMY DEVICE, BY APPLICATIO, 2022-2032 ($MILLION)
  • TABLE 97. SAUDI ARABIA ATHERECTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 98. UAE ATHERECTOMY DEVICE, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 99. UAE ATHERECTOMY DEVICE, BY APPLICATIO, 2022-2032 ($MILLION)
  • TABLE 100. UAE ATHERECTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 101. ARGENTINA ATHERECTOMY DEVICE, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 102. ARGENTINA ATHERECTOMY DEVICE, BY APPLICATIO, 2022-2032 ($MILLION)
  • TABLE 103. ARGENTINA ATHERECTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 104. REST OF LAMEA ATHERECTOMY DEVICE, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 105. REST OF LAMEA ATHERECTOMY DEVICE, BY APPLICATIO, 2022-2032 ($MILLION)
  • TABLE 106. REST OF LAMEA ATHERECTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 107. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
  • TABLE 108. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • TABLE 109. BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
  • TABLE 110. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
  • TABLE 111. BOSTON SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 112. CARDIOVASCULAR SYSTEMS INC.: KEY EXECUTIVES
  • TABLE 113. CARDIOVASCULAR SYSTEMS INC.: COMPANY SNAPSHOT
  • TABLE 114. CARDIOVASCULAR SYSTEMS INC.: OPERATING SEGMENTS
  • TABLE 115. CARDIOVASCULAR SYSTEMS INC.: PRODUCT PORTFOLIO
  • TABLE 116. CARDIOVASCULAR SYSTEMS INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 117. AVINGER INC.: KEY EXECUTIVES
  • TABLE 118. AVINGER INC.: COMPANY SNAPSHOT
  • TABLE 119. AVINGER INC.: OPERATING SEGMENTS
  • TABLE 120. AVINGER INC.: PRODUCT PORTFOLIO
  • TABLE 121. AVINGER INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 122. SPECTRANETICS CORPORATION (PHILIPS HOLDING USA INC.): KEY EXECUTIVES
  • TABLE 123. SPECTRANETICS CORPORATION (PHILIPS HOLDING USA INC.): COMPANY SNAPSHOT
  • TABLE 124. SPECTRANETICS CORPORATION (PHILIPS HOLDING USA INC.): OPERATING SEGMENTS
  • TABLE 125. SPECTRANETICS CORPORATION (PHILIPS HOLDING USA INC.): PRODUCT PORTFOLIO
  • TABLE 126. SPECTRANETICS CORPORATION (PHILIPS HOLDING USA INC.): KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 127. MEDTRONIC PLC: KEY EXECUTIVES
  • TABLE 128. MEDTRONIC PLC: COMPANY SNAPSHOT
  • TABLE 129. MEDTRONIC PLC: OPERATING SEGMENTS
  • TABLE 130. MEDTRONIC PLC: PRODUCT PORTFOLIO
  • TABLE 131. MEDTRONIC PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 132. ST. JUDE MEDICAL INC. (ABBOTT LABORATORIES): KEY EXECUTIVES
  • TABLE 133. ST. JUDE MEDICAL INC. (ABBOTT LABORATORIES): COMPANY SNAPSHOT
  • TABLE 134. ST. JUDE MEDICAL INC. (ABBOTT LABORATORIES): OPERATING SEGMENTS
  • TABLE 135. ST. JUDE MEDICAL INC. (ABBOTT LABORATORIES): PRODUCT PORTFOLIO
  • TABLE 136. ST. JUDE MEDICAL INC. (ABBOTT LABORATORIES): KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 137. STRAUB MEDICAL AG: KEY EXECUTIVES
  • TABLE 138. STRAUB MEDICAL AG: COMPANY SNAPSHOT
  • TABLE 139. STRAUB MEDICAL AG: OPERATING SEGMENTS
  • TABLE 140. STRAUB MEDICAL AG: PRODUCT PORTFOLIO
  • TABLE 141. STRAUB MEDICAL AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 142. BARD PERIPHERAL VASCULAR INC.: KEY EXECUTIVES
  • TABLE 143. BARD PERIPHERAL VASCULAR INC.: COMPANY SNAPSHOT
  • TABLE 144. BARD PERIPHERAL VASCULAR INC.: OPERATING SEGMENTS
  • TABLE 145. BARD PERIPHERAL VASCULAR INC.: PRODUCT PORTFOLIO
  • TABLE 146. BARD PERIPHERAL VASCULAR INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 147. VOLCANO CORPORATION: KEY EXECUTIVES
  • TABLE 148. VOLCANO CORPORATION: COMPANY SNAPSHOT
  • TABLE 149. VOLCANO CORPORATION: OPERATING SEGMENTS
  • TABLE 150. VOLCANO CORPORATION: PRODUCT PORTFOLIO
  • TABLE 151. VOLCANO CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 152. TERUMO CORPORATION: KEY EXECUTIVES
  • TABLE 153. TERUMO CORPORATION: COMPANY SNAPSHOT
  • TABLE 154. TERUMO CORPORATION: OPERATING SEGMENTS
  • TABLE 155. TERUMO CORPORATION: PRODUCT PORTFOLIO
  • TABLE 156. TERUMO CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 157. CARDINAL HEALTH (CORDIS): KEY EXECUTIVES
  • TABLE 158. CARDINAL HEALTH (CORDIS): COMPANY SNAPSHOT
  • TABLE 159. CARDINAL HEALTH (CORDIS): OPERATING SEGMENTS
  • TABLE 160. CARDINAL HEALTH (CORDIS): PRODUCT PORTFOLIO
  • TABLE 161. CARDINAL HEALTH (CORDIS): KEY STRATEGIC MOVES AND DEVELOPMENTS
  • LIST OF FIGURES

  • FIGURE 1. GLOBAL ATHERECTOMY DEVICE MARKET SEGMENTATION
  • FIGURE 2. GLOBAL ATHERECTOMY DEVICE MARKET
  • FIGURE 3. SEGMENTATION ATHERECTOMY DEVICE MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN ATHERECTOMY DEVICE MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALATHERECTOMY DEVICE MARKET
  • FIGURE 11. ATHERECTOMY DEVICE MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 12. ATHERECTOMY DEVICE MARKET FOR DIRECTIONAL ATHERECTOMY SYSTEMS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. ATHERECTOMY DEVICE MARKET FOR PHOTO-ABLATIVE (LASER) ATHERECTOMY SYSTEMS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. ATHERECTOMY DEVICE MARKET FOR ROTATIONAL ATHERECTOMY SYSTEMS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. ATHERECTOMY DEVICE MARKET FOR ORBITAL ATHERECTOMY SYSTEMS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. ATHERECTOMY DEVICE MARKET SEGMENTATION, BY BY APPLICATIO
  • FIGURE 17. ATHERECTOMY DEVICE MARKET FOR PERIPHERAL VASCULAR APPLICATIONS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. ATHERECTOMY DEVICE MARKET FOR CARDIOVASCULAR APPLICATIONS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. ATHERECTOMY DEVICE MARKET FOR NEUROVASCULAR APPLICATIONS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. ATHERECTOMY DEVICE MARKET SEGMENTATION, BY BY END USER
  • FIGURE 21. ATHERECTOMY DEVICE MARKET FOR HOSPITALS SURGICAL CENTERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 22. ATHERECTOMY DEVICE MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 23. ATHERECTOMY DEVICE MARKET FOR RESEARCH LABORATORIES ACADEMIC INSTITUTES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 24. ATHERECTOMY DEVICE MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 25. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 26. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 27. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 28. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 29. COMPETITIVE DASHBOARD
  • FIGURE 30. COMPETITIVE HEATMAP: ATHERECTOMY DEVICE MARKET
  • FIGURE 31. Top player positioning, 2022
  • FIGURE 32. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 33. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 34. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 35. CARDIOVASCULAR SYSTEMS INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 36. CARDIOVASCULAR SYSTEMS INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 37. CARDIOVASCULAR SYSTEMS INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 38. AVINGER INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 39. AVINGER INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 40. AVINGER INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 41. SPECTRANETICS CORPORATION (PHILIPS HOLDING USA INC.): NET SALES, 2020-2022 ($MILLION)
  • FIGURE 42. SPECTRANETICS CORPORATION (PHILIPS HOLDING USA INC.): REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 43. SPECTRANETICS CORPORATION (PHILIPS HOLDING USA INC.): REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 44. MEDTRONIC PLC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 45. MEDTRONIC PLC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 46. MEDTRONIC PLC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 47. ST. JUDE MEDICAL INC. (ABBOTT LABORATORIES): NET SALES, 2020-2022 ($MILLION)
  • FIGURE 48. ST. JUDE MEDICAL INC. (ABBOTT LABORATORIES): REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 49. ST. JUDE MEDICAL INC. (ABBOTT LABORATORIES): REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 50. STRAUB MEDICAL AG: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 51. STRAUB MEDICAL AG: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 52. STRAUB MEDICAL AG: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 53. BARD PERIPHERAL VASCULAR INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 54. BARD PERIPHERAL VASCULAR INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 55. BARD PERIPHERAL VASCULAR INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 56. VOLCANO CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 57. VOLCANO CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 58. VOLCANO CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 59. TERUMO CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 60. TERUMO CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 61. TERUMO CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 62. CARDINAL HEALTH (CORDIS): NET SALES, 2020-2022 ($MILLION)
  • FIGURE 63. CARDINAL HEALTH (CORDIS): REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 64. CARDINAL HEALTH (CORDIS): REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now
RELATED TAGS

Purchase Full Report of
Atherectomy Device Market

Start reading.
This Report and over 66,804+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers